Loon Gangte is an Indian activist living with HIV and hepatitis C, founder of the Delhi Network of Positive People.
However, the key issues holding the final text of these negotiations don’t seem to be getting resolved.
The negotiator’s comments were non-committal but indicated that for now, the RCEP talks have not yet moved decisively into a TRIPS-plus scenario.
Officials from ASEAN member states and other countries meeting in India this week for negotiations on the Regional Comprehensive Economic Partnership (RCEP) should take steps to ensure that the trade deal safeguards human rights, Southeast Asian lawmakers said today.
Trade agreements between countries have a perceivable impact on access to medicines as a result of changes in patent and other national laws in different countries.
The cool reasoning of the Canadian Supreme Court does not acknowledge or reference “external” pressures or the Eli Lilly v. Canada ISDS case. However, courts do not decide cases in a vacuum. This case seems to have been decided in a pressure cooker.
The ’No RCEP’ campaign urges governments to consider the adverse impact of the mega free trade agreement
Goal of implementing most of CETA this summer slips farther from reach.
In the recent “RCEP 18th Round of Talks,” members of civil society organizations and social movements presented their positions vis-à-vis the RCEP.
Through this deal, Swiss pharmaceutical corporations are working to erode India’s ability to produce and supply generic medicines for people across the developing world.
RCEP negotiations have been highly conspiratorial and undemocratic, with all 18 rounds of trade discussions held in secret and no reports shared with the public
The RCEP will only further marginalize women
#NoRCEP week of actions at the 18th TNC Meeting of the Regional Comprehensive Economic Partnership
Trade Justice Pilipinas expresses its opposition to the Regional Comprehensive Economic Partnership agreement or RCEP
Negotiators must protect public health safeguards that enable developing countries like India to keep supplying life-saving affordable medicines for millions of people worldwide.
RCEP magnifies existing inequalities and discriminates against women, indigenous peoples, people living with HIV or other illnesses, people with disabilities,rural communities, farmers and workers
ISDS is increasingly being used by global corporations to challenge health, environment and other public interest laws.
Trade unions, farmers groups, health activists, and other people’s movements are planning to organise a series of events to put pressure on the Government of India to withdraw from RCEP negotiations.
Granting data exclusivity for clinical trials would undermine access to medicines.
A certificate of supplemental protection provides up to two years of additional protection after expiry of a patent.